Dpto. Economía - Ekonomia Saila

Permanent URI for this community

http://hdl.handle.net/2454/10448

Browse

Browsing Dpto. Economía - Ekonomia Saila by Department/Institute "Osasun Zientziak"

Now showing 1 - 3 of 3
  • Thumbnail Image
    PublicationOpen Access
    Cost-utility analysis of prostatic artery embolization for treatment of lower urinary tract symptoms
    (2023) Capdevila, Ferran; Insausti, Íñigo; San Miguel Elcano, Ramón; Sánchez Iriso, Eduardo; Montesino San Martín, Manuel; Ciencias de la Salud; Osasun Zientziak; Economía; Ekonomia
    Purpose: To perform a post hoc cost–utility analysis of a randomized controlled clinical trial comparing prostatic artery embolization (PAE) and transurethral resection of the prostate (TURP) in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia. Materials and Methods: We conducted a cost–utility analysis over a 5-year period to compare PAE versus TURP from a Spanish National Health System perspective. Data were collected from a randomized clinical trial performed at a single institution. Effectiveness was measured as quality-adjusted life years (QALYs), and an incremental cost-effectiveness ratio (ICER) was derived from the cost and QALY values associated with these treatments. Further sensitivity analysis was performed to account for the impact of reintervention on the cost-effectiveness of both procedures. Results: At the 1-year follow-up, PAE resulted in mean cost per patient of €2904.68 and outcome of 0.975 QALYs per treatment. In comparison, TURP had cost €3846.72 per patient and its outcome was 0.953 QALYs per treatment. At 5 years, the cost for PAE and TURP were €4117.13 and €4297.58, and the mean QALY outcome was 4.572 and 4.487, respectively. Analysis revealed an ICER of €2121.15 saved per QALY gained when comparing PAE to TURP at long-term follow-up. Reintervention rate for PAE and TURP was 12% and 0%, respectively. Conclusions: Compared to TURP, in short term, PAE could be considered a cost-effective strategy within the Spanish healthcare system for patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia. However, in long term, the superiority is less apparent due to higher reintervention rates.
  • Thumbnail Image
    PublicationOpen Access
    The economic and social burden of pediatric cerebral palsy in Spain: a cost-of-illness study
    (Frontiers Media, 2025-07-23) Nova Díaz, Diana Marcela; Arana-Rivera, Paloma; Sánchez Iriso, Eduardo; Aguilera Albesa, Sergio; Ciencias de la Salud; Osasun Zientziak; Economía; Ekonomia; Universidad Pública de Navarra / Nafarroako Unibertsitate Publikoa; Gobierno de Navarra / Nafarroako Gobernua
    Background: Cerebral palsy (CP) is the leading cause of motor disability in children and a lifelong condition with no cure, imposing a significant economic burden on families and healthcare systems. However, the economic impact of pediatric CP remains underexplored in Spain, hindering the development of costeective policies. Cost-of-illness (COI) studies are essential to quantify disease burden and guide resource allocation. This study aims to classify and estimate the economic and social costs of pediatric CP in Spain from a societal perspective, considering healthcare, government, and family burdens. Additionally, it evaluates the caregiving burden experienced by primary caregivers. Methods: A bottom–up, disease-specific COI study was conducted from a societal perspective using data from a population-based epidemiological registry of CP. Data collection included structured questionnaires and administrative records from regional healthcare and government sources, covering a 1-year period. The Zarit Burden Interview was used to assess caregiver burden. The study captures direct, indirect, and out-of-pocket costs, including productivity losses associated with caregiving. Results: The study included 148 children with CP (mean age: 9.72) and their primary caregivers (66% female, mean age: 42.97 years). Medical care costs averaged e3,801 (3.72%), while out-of-pocket expenses totalled e7,041 (6.89%), largely driven by complementary and alternative therapies used by 64% of families. Special education represented e8,932 (8.75%), whereas caregiver productivity losses were the largest component (e60,638; 59.37%). The mean annual societal cost per child was e102,135, over thirty times Spain’s mean per capita healthcare expenditure. However, using a conservative assumption that valued the caregiver’s time at the minimum wage, the social costs would be e70,190 per child. Children with severe motor impairment (GMFCS III–V) had nearly twice the cost of those with milder impairments (GMFCS I–II) (1.96; 95% CI: 1.92–2.01). Conclusions: The economic burden of pediatric CP is largely driven by caregiving and non-medical costs, highlighting gaps in financial and social support. These findings call for targeted policies to reduce caregiver strain and enhance funding for assistive services, improving equity in CP care. Additionally, comprehensive cost-eectiveness analyses are needed to guide resource allocation and ensure sustainable support strategies.
  • Thumbnail Image
    PublicationOpen Access
    Parálisis cerebral: nuevos retos en la era de las enfermedades raras
    (Gobierno de Navarra, 2023-04-09) Aguilera Albesa, Sergio; Nova Díaz, Diana Marcela; Aznal Sáinz, Elena; Economía; Ekonomia; Ciencias de la Salud; Osasun Zientziak
    Artículo editorial, que enuncia la importancia del proyecto EPCINA (Estudios de Parálisis Cerebral en Navarra: Evaluación económica, estudio de coste de la enfermedad), el cual se realiza entre el grupo de economía de la salud y el Hospital Universitaria de Navarra.